K2 Principal Fund’s Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 NFYS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-52,372
Closed -$2.1K 344
2024
Q2
$2.1K Sell
52,372
-1,210
-2% -$53 ﹤0.01% 225
2024
Q1
$2.68K Sell
53,582
-2,900
-5% -$127 ﹤0.01% 234
2023
Q4
$2.82K Buy
56,482
+137
+0.2% +$6 ﹤0.01% 214
2023
Q3
$3.94K Buy
56,345
+2,745
+5% +$168 ﹤0.01% 211
2023
Q2
$2.34K Hold
53,600
﹤0.01% 210
2023
Q1
$6.43K Buy
+53,600
New +$6.16K ﹤0.01% 244

Other funds holding NFYS.WS

K2 Principal Fund's NFYS.WS Position: Q3 2024 in Review

K2 Principal Fund sold out of Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) in Q3 2024, closing a stake of 52,372 shares — an estimated $2.1K sold.

K2 Principal Fund first reported a position in NFYS.WS in Q1 2023 and held it in 6 quarters. The position peaked at $6.43K in Q1 2023. 5 funds tracked by Wall St. Rank hold NFYS.WS as of Q3 2024.

  • K2 Principal Fund reported no remaining Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2024 after selling out during the quarter.
  • K2 Principal Fund sold 52,372 Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2024, an estimated $2.1K.
  • K2 Principal Fund first reported a position in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2023 and held it in 6 quarters.
  • K2 Principal Fund's Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $6.43K in Q1 2023.
  • 5 funds tracked by Wall St. Rank held Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2024.

Based on K2 Principal Fund's 13F filing for Q3 2024, filed 15 Nov 2024.